Business Disruption in a Pandemic: Does COVID-19 Excuse Non-Performance of a Contract
Webinar | 04.02.20, 9:00 AM EDT - 10:00 AM EDT
As COVID-19 rapidly evolves and continues to disrupt your business operations in many ways, companies are increasingly confronting the challenges presented by force majeure and related doctrines in their contracts. Join us for a discussion on the five steps companies should consider as a follow on to the alert we previously shared.
For more information, please visit these areas: Corporate and Transactional
Contact
Participants
Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Webinar | 11.17.26
Webinar | 11.13.26
Leveraging the Power of Connection to Better Support our Well-Being
